Chemoimmunotherapy Regimen Approved to Treat DLBCL

TUESDAY, June 11, 2019 -- Polivy (polatuzumab vedotin-piiq), a novel antibody-drug conjugate, received approval to treat patients with diffuse large B-cell lymphoma (DLBCL) in combination with bendamustine and rituximab, the U.S. Food and Drug Administration…

Destiny 2 on the Epic Games Store is…

The studio behind multiplayer FPS Destiny 2 has revealed that the game could potentially head to the Epic Games Store, at its E3 Coliseum event appearance today. The title on PC is currently available for…